ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "FDA Approves Practice-Changing Novel Therapy for Bladder Cancer"
Episode Synopsis
In this episode of Better Edge, Joshua Meeks, MD, PhD, discusses the implications of the FDA's recent approval of TAR-200, a novel therapy for bladder cancer. Having played a key role in the clinical trials and development of this treatment, Dr. Meeks provides an in-depth look at this breakthrough’s potential to transform patient care, especially for those with BCG-unresponsive bladder cancer.
More episodes of the podcast Better Edge : A Northwestern Medicine podcast for physicians
Women Shaping the Future of PM&R
22/10/2025
Ketamine for Treatment-Resistant Depression
20/10/2025
In God we trust